男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語(yǔ)Fran?ais
Opinion
Home / Opinion / Featured Contributors

How Chinese buyers can manage outbound M&A

By Alex Zhang | chinadaily.com.cn | Updated: 2016-08-26 16:05
Share
Share - WeChat

The cartoon of M&A.[Photo/IC]

The world is witnessing a surge in the value and volume of China’s outbound M&A deals. Major target markets include the US and Europe, as well as some emerging markets. Amid this wave of deal activity, Chinese corporates need to ensure they are best-positioned to manage the risk and the deal process in outbound M&A.

Diversification continues to be a key theme across a range of areas. This diversification can be in the investment target, with a range of companies across the US and European markets attracting attention. It can also be in the types of risks these deals face, or in the financing vehicles being used by corporates for outbound activity.

China's M&A outbound deals have reached historic highs in value solely in the first quarter of 2016, as PwC reports. A tally of 115 Chinese outbound M&A deals was publicized, with an overall value of US$82.6 billion, eclipsing all previous annual figures. There is also a myriad of other developments in how Chinese corporates are doing deals, including changes in the business purpose and strategy behind acquisitions.

Furthermore, amid greater uncertainty around regulatory approval, buyers need to be increasingly mindful of securing approval from both China regulators and other regulatory bodies in target markets. There have also been extensive changes over the past several years in the process by which Chinese corporates complete a deal.

Another area seeing growth is in the industries being targeted. In the past, Chinese corporates focused their interest on assets related to energy and natural resources. This is now extending to other areas, such as new energy, technology, media and financial services. Specific sectors continue to dominate deal flow, such as TMT (technology, media and telecommunications) and PMB (pharma, medical and biotech).

1 2 Next   >>|
Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 云林县| 嵊泗县| 公主岭市| 诏安县| 贵南县| 双桥区| 九龙坡区| 垫江县| 尉犁县| 堆龙德庆县| 东丽区| 怀宁县| 永修县| 应城市| 江永县| 新郑市| 泰和县| 崇义县| 临泉县| 乡宁县| 石泉县| 得荣县| 辰溪县| 黑山县| 抚远县| 通州区| 洱源县| 望城县| 西乌珠穆沁旗| 扬中市| 迁安市| 沙坪坝区| 吉水县| 米脂县| 湛江市| 林甸县| 台北县| 文登市| 安平县| 左贡县| 界首市|